How have ERAS and TVTX total returns compared?

Over the past 5 years, ERAS delivered -8.34% and TVTX delivered 17.83% annualized total return. Past performance doesn't predict future results.

Erasca, Inc. (ERAS) vs Travere Therapeutics, Inc. (TVTX)

A side-by-side comparison of Erasca, Inc. and Travere Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ERAS

Erasca, Inc.

$4.96B

$14.30HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

TVTX

Travere Therapeutics, Inc.

$5.19B

$55.80HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

Total return — ERAS vs TVTX

growth of $100 · dividends reinvested · last 5y

ERAS -15.5% (-3.3%/yr)TVTX +320.9% (+33.3%/yr)TVTX compounded faster over this window

ERAS TVTX

ERAS vs TVTX: by the numbers

•TVTX is the larger company ($5.19B vs $4.96B market cap).
•Both run net losses; ERAS's is the smaller (0.00% vs -7.35% net margin).

Metrics side by side

Valuation

Metric	ERAS	TVTX
P/S ratio	N/A	8.78
P/B ratio	13.72	211.61
EV / EBITDA	N/A	248.26
FCF yield	N/A	0.99%

Profitability

Metric	ERAS	TVTX
Gross margin	0.00%	94.41%
Operating margin	0.00%	-6.84%
Net margin	0.00%	-7.35%
ROE	-79.37%	-177.24%
ROIC	-38.03%	-6.19%

Growth (annualized)

Metric	ERAS	TVTX
Revenue CAGR (5Y)	N/A	23.71%
Total return CAGR (5Y)	-8.34%	17.83%

Frequently asked

How have ERAS and TVTX total returns compared?: Over the past 5 years, ERAS delivered -8.34% and TVTX delivered 17.83% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ERAS analysis Full TVTX analysis Interactive comparison tool

Dig into the metrics

Erasca ROE Travere Therapeutics ROE Erasca operating margin Travere Therapeutics operating margin Erasca revenue growth Travere Therapeutics revenue growth Erasca free cash flow Travere Therapeutics free cash flow

Erasca & Travere Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.